Gujarat needs to focus on innovation: DBT

Image
BS Reporter Mumbai/ Ahmedabad
Last Updated : Jan 20 2013 | 1:37 AM IST

Gujarat requires a focus on better higher education and greater public acceptability to make biotechnology sector more vibrant and attract more investment in this sector, noted a top government functionary at the 6th edition of BioInvest 2010 in Ahmedabad on Wednesday. 

Even as Gujarat has evolved itself as a preferred destination for pharmaceuticals and R&D activities, the state is said to be lagging behind in providing quality human resource for the biotechnology sector.

"Gujarat has a huge potential for developing biotechnology industry in the state, but the state has much to do for improving higher education, which will further open investment avenues in this sector," said Dr M K Bhan, secretary, Department of Biotechnology (DBT), Government of India. 

Bhan noted that Gujarat stands at fifth position with respect to the development of biotechnology industry among other states of the country. "Gujarat stands fifth, while states like Tamil Nadu, Karnataka, Andhra Pradesh are doing fairly good among other states,” he told reporters on the sidelines of the conference today.

"In states like Andhra Pradesh and Karnataka, the innovation machinery is good, while Gujarat is good in manufacturing. So, in order to bring more innovation to this sector there is a need to make 2-3 universities here that has its focus on life sciences. Gujarat can do better in higher education but the State lags entrepreneurship in higher education," stated Bhan.

Ravi Saxena, additional chief secretary, Department of Science & Technology, government of Gujarat maintained that Gujarat holds strong base in industries like pharmaceutical, chemicals, and food and beverages, which would provide an ideal ecosystem for the development of the biotech industry in the state.

"With the current landscape already comprising of more than 127 Biotechnology companies and many support organisations, the government is committed to develop the biotech sector in Gujarat in a holistic way, by creating not only a conducive environment, but also providing good infrastructure and support," Saxena added. Commenting about the fresh project proposals from Gujarat, Bhan stated that the state was slow in sending project proposals in the biotech sector.

However, Gujarat already has Ahmedabad and Vadodara as prominent biotech clusters having presence of some of the notable companies including Veeda Research, Lambda Therapeutics besides several others.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 23 2010 | 12:00 AM IST

Next Story